These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
142 related articles for article (PubMed ID: 17478740)
21. Cost-effectiveness of thrombolysis within 4.5 hours of acute ischemic stroke in China. Pan Y; Chen Q; Zhao X; Liao X; Wang C; Du W; Liu G; Liu L; Wang C; Wang Y; Wang Y; PLoS One; 2014; 9(10):e110525. PubMed ID: 25329637 [TBL] [Abstract][Full Text] [Related]
22. The iScore predicts effectiveness of thrombolytic therapy for acute ischemic stroke. Saposnik G; Fang J; Kapral MK; Tu JV; Mamdani M; Austin P; Johnston SC; ; Stroke; 2012 May; 43(5):1315-22. PubMed ID: 22308252 [TBL] [Abstract][Full Text] [Related]
24. Utilization of intravenous tissue plasminogen activator for ischemic stroke: are there sex differences? Allen NB; Myers D; Watanabe E; Dostal J; Sama D; Goldstein LB; Lichtman JH Cerebrovasc Dis; 2009; 27(3):254-8. PubMed ID: 19176959 [TBL] [Abstract][Full Text] [Related]
25. Risks and Benefits Associated With Prestroke Antiplatelet Therapy Among Patients With Acute Ischemic Stroke Treated With Intravenous Tissue Plasminogen Activator. Xian Y; Federspiel JJ; Grau-Sepulveda M; Hernandez AF; Schwamm LH; Bhatt DL; Smith EE; Reeves MJ; Thomas L; Webb L; Bettger JP; Laskowitz DT; Fonarow GC; Peterson ED JAMA Neurol; 2016 Jan; 73(1):50-9. PubMed ID: 26551916 [TBL] [Abstract][Full Text] [Related]
26. The use and misuse of thrombolytic therapy within the Veterans Health Administration. Keyhani S; Arling G; Williams LS; Ross JS; Ordin DL; Myers J; Tyndall G; Vogel B; Bravata DM Med Care; 2012 Jan; 50(1):66-73. PubMed ID: 22182924 [TBL] [Abstract][Full Text] [Related]
27. Current status of intravenous thrombolysis for acute ischemic stroke in Asia. Sharma VK; Ng KW; Venketasubramanian N; Saqqur M; Teoh HL; Kaul S; Srivastava PM; Sergentanis T; Suwanwela N; Nguyen TH; Lawrence Wong KS; Chan BP Int J Stroke; 2011 Dec; 6(6):523-30. PubMed ID: 22111797 [TBL] [Abstract][Full Text] [Related]
30. Cost-effectiveness of intravenous thrombolysis with alteplase within a 3-hour window after acute ischemic stroke. Ehlers L; Andersen G; Clausen LB; Bech M; Kjølby M Stroke; 2007 Jan; 38(1):85-9. PubMed ID: 17122430 [TBL] [Abstract][Full Text] [Related]
31. A pharmacoeconomic assessment of recombinant tissue plasminogen activator therapy for acute ischemic stroke in a tertiary hospital in China. Yan X; Hu HT; Liu S; Sun YH; Gao X Neurol Res; 2015 Apr; 37(4):352-8. PubMed ID: 25297471 [TBL] [Abstract][Full Text] [Related]
32. Cost-effectiveness analysis of tissue plasminogen activator in acute ischemic stroke in Iran. Amiri A; Goudarzi R; Amiresmaili M; Iranmanesh F J Med Econ; 2018 Mar; 21(3):282-287. PubMed ID: 29105528 [TBL] [Abstract][Full Text] [Related]